Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Forecast till 2030
ID: MRFR/MED/0694-HCR | 80 Pages | Published By Kinjoll Dey on March 2023
Speak to Analyst
Request a Free Sample
Immunoassay Analyzers Market
Immunoassay Analyzers Market is projected to be worth USD 1,588.16 Millionby 2030, registering a CAGR of 5.40% during the forecast period (2022-2030).
$1,588.16 Million
5.40%
North America
2022-2030
Immunoassay Analyzers Market Scenario
The Immunoassay Analyzers Market is anticipated to reach USD 1,588.16 Million by 2030 at 5.40% CAGR during the forecast period 2022-2030.Immunoassay is a test that measures the concentration of analytes in blood samples, this is done by an instrument known as immunoassay analyzer. This instrument measures the presence or concentration of proteins in analyte samples; using antigen-antibody binding properties. Increasing demand for the new and better drugs has led to increase the number of testing procedures. These assays are used to monitor and measure different types of diseases. The immunoassay analyzer market is majorly driven by an increasing prevalence of different infectious, immunological or metabolic diseases, increasing demand of advanced diagnostic devices and recent trends of automation and integration which together have led to the introduction of innovative products in immunoassay analyzer market. According to the Center of Disease Control and Prevention, over 17.8 million people suffers from infectious diseases each year. Beside this, rising number of patient suffering from cardiovascular diseases and diabetes has stimulated the demand for the different drugs and tests ultimately led to the growth of the immunoassay analyzer market. Furthermore, increasing geriatric population, changing lifestyle, growing habit of smoking and drinking along with increasing spending on healthcare have also fuelled the growth of immunoassay analyzer market. However, test and assays performed are strictly monitor and thus, strict regulatory requirement and high cost of the instruments may hinder this market’s growth.
Intended Audience
- Immunoassay Analyzers Manufacturer
- Immunoassay Analyzers Supplier
- Research and Development (R&D) Companies
- Independent Research Laboratories
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Figure 1- Global immunoassay analyzers market, by application 
Source- Annual reports, press release, white paper, company presentationÂ
Segmentation
The immunoassay analyzer immunoassay analyzer market is segmented on the basis of instruments, applications, and end users.
On the basis of instruments, the immunoassay analyzer market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.
On the basis of application, the immunoassay analyzer market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.
On the basis of end users, the immunoassay analyzer market is categorized into hospitals, diagnostic laboratories, research institutes, and others.Â
Regional Analysis
America dominates the immunoassay analyzer market owing to large patient population and strong government support. Increasing diabetic population has also contributed in the growth of the immunoassay analyzer market market. Â According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes. In addition to this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. Government and many companies are conducting many seminar in order to create awareness among the people which is created a room for the market growth.
Europe commands the second largest immunoassay analyzer market, which is followed by Asia Pacific. Presence of huge patient pool, and increasing government support will drive the immunoassay analyzer market in Europe. Asia Pacific is the fastest growing region for the market due to the presence of a rapidly developing economies, and increasing need for the better treatment. China and India are the major contributor for the immunoassay analyzer market.
On the other hand, the Middle East & Africa has the least share in the immunoassay analyzer market due to presence of poor economy especially in Africa region. Middle East holds the major share in the Middle East & Africa immunoassay analyzer market owing to well-developed healthcare sector and huge healthcare expenditure.Â
Key Players
Some of the major key player in the immunoassay analyzer market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK).Â
Market Assessment
Source- World Health Organization (WHO), White Paper, Company Presentation, Annual Reports
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 1,588.16 Million |
| CAGR | 5.40% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Instruments, Applications, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK). |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Immunoassay analyzers market is expected to expand at 5.40% CAGR from 2022-2030.
Rising demand of advanced diagnostic devices and increasing prevalence of chronic diseases are major drivers of the global immunoassay analyzers market.
High costs of instruments and strict regulations pertaining to the approval of instruments can impede the global immunoassay analyzers market growth.
The Americas can dominate the global immunoassay analyzers market due to the large number of diabetics.
DiaSorin S.p., Siemens Ltd., Randox Laboratories Ltd., The Binding Site Group Ltd., F. Hoffmann-La Roche Ltd., Biokit S.A, Beckman Coulter, Inc., Olympus Corporation, Ortho Clinical Diagnostics, bioMérieux Private Limited, Abbott, Thermo Fisher Scientific, Nova Century Scientific, Inc., Merck KGaA, and Immunodiagnostic Systems are prominent players of the global immunoassay analyzers market.
